$JANX

$17.26 +$0.57 (3.42%) Close

$JANX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$JANX Management Team

Dr. David Campbell

President

Chief Executive Officer

Founder

Director

Age 66

Compensation $8.975M USD

Sex Male

Dr. Thomas Diraimondo

Co-Founder

Chief Scientific Officer

Age 39

Compensation $3.415M USD

Sex Male

Mr. Charles Winter

Chief Technical Officer

Age 56

Compensation $1.608M USD

Sex Male

Mr. Andy Meyer

Chief Business Officer

Age 41

Compensation -

Sex Male

Ms. Janeen Doyle

Chief Corporate and Business Development Officer

Age -

Compensation -

Sex Female

Dr. Ronald Barrett

Independent Chairman of the Board

Age 69

Compensation $416.1K USD

Sex Male

Dr. William Go

Chief Medical Officer

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. David Campbell President Chief Executive Officer Founder Director	66	$8.975M USD	Male
Dr. Thomas Diraimondo Co-Founder Chief Scientific Officer	39	$3.415M USD	Male
Mr. Charles Winter Chief Technical Officer	56	$1.608M USD	Male
Mr. Andy Meyer Chief Business Officer	41	-	Male
Ms. Janeen Doyle Chief Corporate and Business Development Officer	-	-	Female
Dr. Ronald Barrett Independent Chairman of the Board	69	$416.1K USD	Male
Dr. William Go Chief Medical Officer	-	-	Male

Board of Directors

From the proxy statement filed Apr 28, 2026

Directors

serving now

Independent

8 of 9

stated in the proxy

Average tenure

4.7 years

from year joined

CEO also chairs the board

Ron Barrett, Ph.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Natasha Hernday	54	2024 2 years	Independent	None stated	Xoma Corp.	$374,216
Eric Dobmeier	57	2024 2 years	Independent	None stated	Structure Therapeutics, Inc.	$376,091
Sheila Gujrathi, M.D. Leaving at the meeting	55	2021 5 years	Independent	None stated	Ventyx Biosciences, Inc.	$370,466
Alana McNulty Leaving at the meeting	63	2021 5 years	Independent	Audit	None stated	$379,841
Vickie Capps	64	2021 5 years	Independent	None stated	Orthofix Medical, Inc.	$389,216
Jake Simson, Ph.D.	40	2021 5 years	Independent	None stated	Tyra Biosciences, Inc., Bicara Therapeutics, Inc., Septerna Inc.	$381,591
David Campbell, Ph.D. CEO	67	2017 9 years	Not independent	None stated	None stated	Paid as CEO
Ron Barrett, Ph.D. Board chair	70	2021 5 years	Independent	None stated	None stated	$420,779
Winston Kung	50	2022 4 years	Independent	Audit	Corbus Pharmaceuticals	$379,841

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$JANX Management Team

Dr. David Campbell

Dr. Thomas Diraimondo

Mr. Charles Winter

Mr. Andy Meyer

Ms. Janeen Doyle

Dr. Ronald Barrett

Dr. William Go

Board of Directors

Related-party transactions

No related-party transactions disclosed